Skip to main content

Advertisement

SpringerLink
Log in

Treatment of comorbidities of chronic daily headache

  • Published:
Current Treatment Options in Neurology Aims and scope Submit manuscript

Opinion statement

The treatment of chronic daily headaches should focus not only on establishing an effective plan for pain therapy but also on addressing factors that may diminish progression from episodic headache toward chronic daily headache. These measures may translate into better treatment efficacy and satisfaction, as well as decrease the headache burden. Because episodic migraine progresses to chronic daily headache in some (not most) individuals, research will increasingly focus on identifying factors associated with progression, such as specific genetic and environmental risk factors, including comorbidities. Ultimately, the assessment of the migraine patient will include an evaluation of risk factors for progression. In addition to the symptom profile, evaluation will increasingly focus on comorbidities, ictal and interictal functional consequences of migraine, health-related quality of life, treatment needs, and treatment preferences. Estimation of the risk of progression will incorporate assessments of comorbidity, exposures, and eventually biomarkers. Those with high risk of progression will be more aggressively treated, not just to relieve current pain and disability but to prevent progression. Therefore, treatment will focus on decreasing current burden and preventing future burden.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Lipton RB, Pan J: Is migraine a progressive brain disease? JAMA 2004, 291:493–494.

    Article  PubMed  CAS  Google Scholar 

  2. Scher AI, Stewart WF, Liberman J, Lipton RB: Prevalence of frequent headache in a population sample. Headache 1998, 38:497–506.

    Article  PubMed  CAS  Google Scholar 

  3. Castillo J, Munoz P, Guitera V, Pascual J: Epidemiology of chronic daily headache in the general population. Headache 1999, 39:190–196.

    Article  PubMed  CAS  Google Scholar 

  4. Katsarava Z, Schneeweiss S, Kurth T, et al.: Incidence and predictors for chronicity of headache in patients with episodic migraine. Neurology 2004, 62:788–790.

    PubMed  CAS  Google Scholar 

  5. Burstein R, Yarnitsky D, Goor-Aryeh I, et al.: An association between migraine and cutaneous allodynia. Ann Neurol 2000, 47:614–624.

    Article  PubMed  CAS  Google Scholar 

  6. Burstein R, Collins B, Jakubowski M: Defeating migraine pain with triptans: a race against the development of cutaneous allodynia. Ann Neurol 2004, 55:19–26.

    Article  PubMed  CAS  Google Scholar 

  7. Couch JR, Lipton RB, Stewart WF, Scher AI: Head or neck injury increases the risk of chronic daily headache. A population-based study. Neurology 2007, 69:1169–1177.

    Article  PubMed  Google Scholar 

  8. Scher AI, Stewart WF, Ricci JA, Lipton RB: Factors associated with the onset and remission of chronic daily headache in a population-based study. Pain 2003, 106:81–89.

    Article  PubMed  CAS  Google Scholar 

  9. Bigal ME, Sheftell FD, Rapoport AM, et al.: Chronic daily headache: identification of factors associated with induction and transformation. Headache 2002, 42:575–581.

    Article  PubMed  Google Scholar 

  10. Bigal ME, Lipton RB: Obesity is a risk factor for transformed migraine but not chronic tension-type headache. Neurology 2006, 67:252–257.

    Article  PubMed  Google Scholar 

  11. Juang KD, Wang SJ, Fuh JL, et al.: Comorbidity of depressive and anxiety disorders in chronic daily headache and its subtypes. Headache 2000, 40:818–823.

    Article  PubMed  CAS  Google Scholar 

  12. Peterlin BL, Ward T, Lidicker J, Levin M: A retrospective, comparative study on the frequency of abuse in migraine and chronic daily headache. Headache 2007, 47:397–401.

    PubMed  Google Scholar 

  13. Scher AI, Stewart WF, Lipton RB: Caffeine as a risk factor for chronic daily headache: a population-based study. Neurology 2004, 63:2022–2027.

    PubMed  CAS  Google Scholar 

  14. Tietjen GE, Brandes JL, Digre KB, et al.: High prevalence of somatic symptoms and depression in women with disabling chronic headache. Neurology 2007, 68:134–140.

    Article  PubMed  CAS  Google Scholar 

  15. Zed PJ, Loewen PS, Robinson G: Medication-induced headache: overview and systematic review of therapeutic approaches. Ann Pharmacother 1999, 33:61–72.

    Article  PubMed  CAS  Google Scholar 

  16. Wang SJ, Fuh JL, Lu SR, et al.: Chronic daily headache in Chinese elderly: prevalence, risk factors, and biannual follow-up. Neurology 2000, 54:314–319.

    PubMed  CAS  Google Scholar 

  17. Lu SR, Fuh JL, Chen WT, et al.: Chronic daily headache in Taipei, Taiwan: prevalence, follow-up and outcome predictors. Cephalalgia 2001, 21:980–986.

    Article  PubMed  CAS  Google Scholar 

  18. Bigal ME, Liberman JN, Lipton RB: Obesity and migraine: a population study. Neurology 2006, 66:545–550.

    Article  PubMed  Google Scholar 

  19. Bigal ME, Lipton RB, Holland PR, Goadsby PJ: Obesity, migraine, and chronic migraine: possible mechanisms of interaction. Neurology 2007, 68:1851–1861.

    Article  PubMed  Google Scholar 

  20. Jennum P, Hein HO, Suadicani P, Gyntelberg F: Headache and cognitive dysfunctions in snorers. A cross-sectional study of 3323 men aged 54 to 74 years: the Copenhagen Male Study. Arch Neurol 1994, 51:937–942.

    PubMed  CAS  Google Scholar 

  21. Ulfberg J, Carter N, Talback M, Edling C: Headache, snoring and sleep apnoea. J Neurol 1996, 243:621–625.

    Article  PubMed  CAS  Google Scholar 

  22. Scher AI, Lipton RB, Stewart WF: Habitual snoring as a risk factor for chronic daily headache. Neurology 2003, 60:1366–1368.

    PubMed  CAS  Google Scholar 

  23. Verri AP, Proietti CA, Galli C, et al.: Psychiatric comorbidity in chronic daily headache. Cephalalgia 1998, 18(Suppl 21):45–49.

    Google Scholar 

  24. Couch JR, Ziegler DK, Hassanein RS: Evaluation of the relationship between migraine headache and depression. Headache 1975, 15:41–50.

    Article  PubMed  CAS  Google Scholar 

  25. Patel NV, Bigal ME, Kolodner KB, et al.: Prevalence and impact of migraine and probable migraine in a health plan. Neurology 2004, 63:1432–1438.

    PubMed  CAS  Google Scholar 

  26. Mathew NT, Reuveni U, Perez F: Transformed or evolutive migraine. Headache 1987, 27:102–106.

    Article  PubMed  CAS  Google Scholar 

  27. McWilliams LA, Goodwin RD, Cox BJ: Depression and anxiety associated with three pain conditions: results from a nationally representative sample. Pain 2004, 111:77–83.

    Article  PubMed  Google Scholar 

  28. Merikangas KR, Angst J, Isler H: Migraine and psychopathology. Results of the Zurich cohort study of young adults. Arch Gen Psychiatry 1990, 47:849–853.

    PubMed  CAS  Google Scholar 

  29. Breslau N, Schultz LR, Stewart WF, et al.: Headache types and panic disorder: directionality and specificity. Neurology 2001, 56:350–354.

    PubMed  CAS  Google Scholar 

  30. Maizels M, Burchette R: Somatic symptoms in headache patients: the influence of headache diagnosis, frequency, and comorbidity. Headache 2004, 44:983–993.

    Article  PubMed  Google Scholar 

  31. Zwart JA, Dyb G, Hagen K, et al.: Analgesic use: a predictor of chronic pain and medication overuse headache: the Head-HUNT Study. Neurology 2003, 61:160–164.

    PubMed  Google Scholar 

  32. Bigal ME, Rapoport AM, Sheftell FD, et al.: Transformed migraine and medication overuse in a tertiary headache centre-clinical characteristics and treatment outcomes. Cephalalgia 2004, 24:483–490.

    Article  PubMed  CAS  Google Scholar 

  33. Silverman K, Evans SM, Strain EC, Griffiths RR: Withdrawal syndrome after the double-blind cessation of caffeine consumption. N Engl J Med 1992, 327:1109–1114.

    Article  PubMed  CAS  Google Scholar 

  34. Bahra A, Walsh M, Menon S, Goadsby PJ: Does chronic daily headache arise de novo in association with regular use of analgesics? Headache 2003, 43:179–190.

    Article  PubMed  Google Scholar 

  35. Wilkinson SM, Becker WJ, Heine JA: Opiate use to control bowel motility may induce chronic daily headache in patients with migraine. Headache 2001, 41:303–309.

    Article  PubMed  CAS  Google Scholar 

  36. Zeeberg P, Olesen J, Jensen R: Discontinuation of medication overuse in headache patients: recovery of therapeutic responsiveness. Cephalalgia 2006, 26:1192–1198.

    Article  PubMed  CAS  Google Scholar 

  37. Pini LA, Cicero AF, Sandrini M: Long-term follow-up of patients treated for chronic headache with analgesic overuse. Cephalalgia 2001, 21:878–883.

    Article  PubMed  CAS  Google Scholar 

  38. Headache Classification Subcommittee, International Headache Society: The International Classification of Headache Disorders, 2nd edition. Cephalalgia 2004, 24(Suppl 1):9–160.

    Google Scholar 

  39. James WP, Astrup A, Finer N, et al.: Effect of sibutramine on weight maintenance after weight loss: a randomised trial. STORM Study Group. Sibutramine Trial of Obesity Reduction and Maintenance. Lancet 2000, 356:2119–2125.

    Article  PubMed  CAS  Google Scholar 

  40. Bray GA, Ryan DH, Gordon D, et al.: A double-blind randomized placebo-controlled trial of sibutramine. Obes Res 1996, 4:263–270.

    PubMed  CAS  Google Scholar 

  41. Sjostrom L, Rissanen A, Andersen T, et al.: Randomised placebo-controlled trial of orlistat for weight loss and prevention of weight regain in obese patients. European Multicentre Orlistat Study Group. Lancet 1998, 352:167–172.

    Article  PubMed  CAS  Google Scholar 

  42. Silberstein SD, Hulihan J, Karim MR, et al.: Efficacy and tolerability of topiramate 200 mg/d in the prevention of migraine with/without aura in adults: a randomized, placebo-controlled, double-blind, 12-week pilot study. Clin Ther 2006, 28:1002–1011.

    Article  PubMed  CAS  Google Scholar 

  43. Brandes JL, Saper JR, Diamond M, et al.: Topiramate for migraine prevention: a randomized controlled trial. JAMA 2004, 291:965–973.

    Article  PubMed  CAS  Google Scholar 

  44. Storey JR, Calder CS, Hart DE, Potter DL: Topiramate in migraine prevention: a double-blind, placebo-controlled study. Headache 2001, 41:968–975.

    Article  PubMed  CAS  Google Scholar 

  45. Maggioni F, Ruffatti S, Dainese F, et al.: Weight variations in the prophylactic therapy of primary headaches: 6-month follow-up. J Headache Pain 2005, 6:322–324.

    Article  PubMed  Google Scholar 

  46. Berilgen MS, Bulut S, Gonen M, et al.: Comparison of the effects of amitriptyline and flunarizine on weight gain and serum leptin, C peptide and insulin levels when used as migraine preventive treatment. Cephalalgia 2005, 25:1048–1053.

    Article  PubMed  CAS  Google Scholar 

  47. Krymchantowski AV, Silva MT, Barbosa JS, Alves LA: Amitriptyline versus amitriptyline combined with fluoxetine in the preventative treatment of transformed migraine: a double-blind study. Headache 2002, 42:510–514.

    Article  PubMed  Google Scholar 

  48. Freitag FG, Diamond S, Diamond ML, Urban GJ: Divalproex in the long-term treatment of chronic daily headache. Headache 2001, 41:271–278.

    Article  PubMed  CAS  Google Scholar 

  49. Parker RJ, Hardinge M, Jeffries C: Snoring [review]. BMJ 2005, 331:1063.

    Article  PubMed  Google Scholar 

  50. Friedman M, Lin HC, Gurpinar B, Joseph NJ: Minimally invasive single-stage multilevel treatment for obstructive sleep apnea/hypopnea syndrome. Laryngoscope 2007, 117:1859–1863.

    Article  PubMed  Google Scholar 

  51. Walker-Engstrom ML, Tegelberg A, Wilhelmsson B, Ringqvist I: 4-year follow-up of treatment with dental appliance or uvulopalatopharyngoplasty in patients with obstructive sleep apnea: a randomized study. Chest 2002, 121:739–746.

    Article  PubMed  Google Scholar 

  52. Loredo JS, Ancoli-Israel S, Kim EJ, et al.: Effect of continuous positive airway pressure versus supplemental oxygen on sleep quality in obstructive sleep apnea: a placebo-CPAP-controlled study. Sleep 2006, 29:564–571.

    PubMed  Google Scholar 

  53. Verse T, Pirsig W, Stuck BA, et al.: Recent developments in the treatment of obstructive sleep apnea. Am J Respir Med 2003, 2:157–168.

    PubMed  Google Scholar 

  54. Penzien DB, Rains JC, Andrasik F: Behavioral management of recurrent headache: three decades of experience and empiricism. Appl Psychophysiol Biofeedback 2002, 27:163–181.

    Article  PubMed  Google Scholar 

  55. Grazzi L, Andrasik F, D’Amico D, et al.: Behavioral and pharmacologic treatment of transformed migraine with analgesic overuse: outcome at 3 years. Headache 2002, 42:483–490.

    Article  PubMed  Google Scholar 

  56. Couch JR, Hassanein RS: Amitriptyline in migraine prophylaxis. Arch Neurol 1979, 36:695–699.

    PubMed  CAS  Google Scholar 

  57. Katsarava Z, Muessig M, Dzagnidze A, et al.: Medication overuse headache: rates and predictors for relapse in a 4-year prospective study. Cephalalgia 2005, 25:12–15.

    Article  PubMed  CAS  Google Scholar 

  58. Trucco M, Meineri P, Ruiz L: Preliminary results of a withdrawal and detoxification therapeutic regimen in patients with probable chronic migraine and probable medication overuse headache. J Headache Pain 2005, 6:334–337.

    Article  PubMed  Google Scholar 

  59. Mei D, Ferraro D, Zelano G, et al.: Topiramate and triptans revert chronic migraine with medication overuse to episodic migraine. Clin Neuropharmacol 2006, 29:269–275.

    Article  PubMed  CAS  Google Scholar 

  60. Sheftell FD, Rapoport AM, Tepper SJ, Bigal ME: Naratriptan in the preventive treatment of refractory transformed migraine: a prospective pilot study. Headache 2005, 45:1400–1406.

    Article  PubMed  Google Scholar 

  61. Bonuccelli U, Nuti A, Lucetti C, et al.: Amitriptyline and dexamethasone combined treatment in drug-induced headache. Cephalalgia 1996, 16:198–200.

    Article  PubMed  CAS  Google Scholar 

  62. Loder E, Biondi D: Oral phenobarbital loading: a safe and effective method of withdrawing patients with headache from butalbital compounds. Headache 2003, 43:904–909.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurology and the Montefiore Headache Center, Albert Einstein College of Medicine, 1165 Morris Park Avenue, Rousso Building, Room 330, Bronx, NY, 10461, USA

    Marcelo E. Bigal

Authors
  1. Sait Ashina
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Richard B. Lipton
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Marcelo E. Bigal
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Marcelo E. Bigal.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ashina, S., Lipton, R.B. & Bigal, M.E. Treatment of comorbidities of chronic daily headache. Curr Treat Options Neurol 10, 36–43 (2008). https://doi.org/10.1007/s11940-008-0005-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11940-008-0005-1

Keywords

Search

Navigation